long term management of cardiac tachyarrhythmias Flashcards
what are options for long term management of cardiac tachyarrhythmias
- anti arrhythmic drug therapy
- ablation therapy
- device therapy
what are class 1 drugs
membrane depressant drugs that reduce the rate of entry of Na into the cell (sodium channel blockers)
slow conduction, delay recovery and reduce the spontaneous discharge rate of myocardial cells
lengthen the action potential
what is class 1a drug
Disopyramide
lengthens action potential
what is class 1b drug
Lidocaine, mexiletine
shortens action potential
what is class 1c drug
Flecainide, propafenone
no effect on action potential
what are class 2 drugs
these are anti sympathetic drugs that prevent the effect go catecholamines on the action potential
most are beta1 blockers and suppress the AV node conduction, which may be effective in preventing attacks of junctional tachycardia, and may help to control the ventricular rate during paroxysms of other forms of SVT
advised to use beta blocker therapy either alone or in combination with other anti arrhythmic drugs in patients with symptomatic tachyarrhythmias
what is class 2 drug
Atenolol, Acebutolol, Bisoprolol, Propanolol, Esmolol
block b-adenoceptors
what are class 3 drugs
these prolong the action potential usually by blocking the rapid components of the delayed rectifier potassium current and do not affect sodium transport through the membrane
lengthen the action potential
what is a class 3 drug
Amiodarone, dronedarone, sotalol, dofetilide
lengthen action potential
what are class 4 drugs
The non-dihydropyridine calcium channel blockers are particularly effective at slowing conduction at nodal tissue
Can help prevent attacks of junctional tachycardia (AVNRT and AVRT) and may control ventricular rates during paroxysms of other forms of SVT
what is a class 4 drugs
calcium channel blockers eg Verapamil and diltiazem
reduce the plateau phase of action potential
what is catheter ablation
frequency employed in the management of symptomatic tachyarrhythmias
when should catheter ablation be used as first line therapy
symptomatic patients with a pre excited ECG because of accessory pathway conduction